These results suggest that the expression of DIAPH3 is not conducive to the anti-tumor effect of the body, and the immune checkpoint analysis also revealed that achieving satisfactory results by immune checkpoint blocking therapy is challenging. Here, DIAPH3 is linked to neoplasm.